An amphotropic retroviral vector, LgAL(AMo + PyFl 01) containing a human adenosine deaminase (ADA) cDNA was used to optimize procedures for the lasting genetic modification of the hematopoietic system of mice. The highest number of retrovirally infected cells in the hematopoietic tissues of long-term reconstituted mice was observed after transplantation of bone marrow (BM) cells that had been cocultured in the presence of both interleukin-la (IL-la) and IL-3. A significantly lower number was detected when IL-1 a was omitted from such cocultures. The yield of cells that generate spleen colony-forming cells (CFU-S) in the BM of lethally irradiated recipients (MRA-CFU-S) significantly improved on inclusion of the adherent cell fraction ETROVIRUS-MEDIATED gene transfer into pluri-R potent hematopoietic stem cells (PHSC) has proven to be a valuable tool for the study of the developmental potential of PHSC after tran~plantation.'-~ These studies confirmed the potential usefulness of such procedures in gene therapy protocols aimed at the lasting correction of genetic defects affecting the hematopoietic system. Initially, difficulties were encountered regarding the expression of the introduced sequences.'~~,~ Recently, however, these problems have been overcome and currently, stable long-term expression can be obtained with various retroviral vectors and inserted sequences? One of the prime candidates for bone marrow (BM) gene therapy is severe combined immunodeficiency (SCID) caused by the absence of functional adenosine deaminase (ADA)." Patients suffering from ADA-SCID do not have sufficient T and B cells, which results in a lack of both humeral and cell-mediated immune function." The transfer of a functional copy of the hADA-gene into these patient's PHSC should result in the lasting restoration of their immune functions and thereby cure the disease.
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Efficient transfer of the hADA-gene into murine PHSC and subsequent expression of the gene in the progeny of these cells has been obtained with a number of different
We have previously described the generation of a retroviral vector in which the Moloney Murine Leukemia Virus (Mo-MuLV) enhancer in the long-terminal repeat (LTR) had been replaced by an enhancer from a mutant polyoma virus (PyFIOl) that was selected to grow on em-0 1993 by The American Society of Hematology.
bryonal carcinoma cells. We showed that this vector directs the expression of the neoR-gene in embryonal carcinoma cells as well as in spleen colony-forming cells (CFU-S) and their progeny. 17 To test the usefulness of this modified LTR for therapeutic applications, the neoR-gene was replaced by a hADA-cDNA. The resulting plasmid, encoded pLgAL( AMo + PyFlOl), was subsequently used to generate an amphotropic recombinant retrovirus producing cell line. Transplantation of LgAL(AMo + PyFlOl)-infected BM resulted in detectable hADA-activity in the various hematopoietic organs as well as in the circulating white blood cells (WBCs). Retransplantation of the BM of the first recipient into secondary recipients showed that expression persisted in the myeloid, lymphoid, and erythroid lineages." An additional advantage of retroviral vectors based on this hybrid LTR over vectors based on the Mo-MuLV LTR is that its leukemogenic potential is strongly reduced.'' Retrovirus-mediated gene transfer into primitive hematopoietic cells has been optimized using the CFU-S assay.2,20-23 These studies revealed that 100% transduction of CFU-S can be achieved when BM cells from 5-fluorouracil (5-FU) pre-treated mice are cocultivated with a high virustiter-producing cell line (ie, > IO5 CFU/mL) in the presence of interleukin-3 (IL-3).2-20 Because IL-1 a and IL-3 synergize in stimulating the proliferation of pluripotent hematopoietic precursors24325 most laboratories include IL-I a in the coculture medium.4.5.12.17.18,26 H owever, despite its abundant use, an effect of IL-la on the infection or survival of primitive hematopoietic cells during cocultivation has never been described. Studies using the CFU-S assay have provided valuable quantitative information on the infection of a very primitive hematopoietic cell type. However, the acquired information is not directly applicable to the infection of PHSC, since it was firmly established that CFU-S are not equivalent to PHSC.27-29 Therefore, we have turned to another quantifiable assay. We measured the capacity of cells in a graft to repopulate the BM of lethally irradiated recipients with CFU-S (MRA-CFU-S). These cells are functionally distinct from CFU-S because cells with marrow-repopulating ability and not CFU-S are capable to sustain continuous in vitro hematopoiesis in long-term BM In addition, the phenotypic characteristics of MRA-CFU-S as detected in stem cell purification protocols indicate that they closely resemble 
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PHSC that provide for the long-term repopulation of a hematopoietic ~y s t e m . ~~~~ We have studied the effect of IL-1 a, IL-3, and the recently described growth factor stem cell factor (SCF) also termed mast cell growth on the survival and infection of MRA-CFU-S during cocultivation. All experiments were performed in the presence of IL-6, which is produced in large amounts during cocultivation of retrovirus producing cells and BM cells.37 The results obtained with the MRA-CFU-S assay are compared with the infection efficiency of PHSC following long-term reconstitution of the hematopoietic system.
MATERIALS AND METHODS
Animals. BCBA (C57BLILiARij X CBA/BrARij)FI mice were bred and maintained under specified pathogen-free conditions in our institute. For up to 30 days after lethal irradiation (8.5 Gy, 0.70 Gy/ min, 137Cs gamma-rays) the mice were fed 200 mg/L Delvocid (50% natamycin, 50% lactose; Gist-brocades Delft, The Netherlands), 100 mg/L polymyxin B sulfate U.S.P. (Pfizer Inc, New York), 100 mg/ L Cyproxin-750 (75% ciprofloxacine; Bayer, Leverkusen, Germany), and 20 g/L sucrose via their drinking water.
The POC-1 cell line,18 a subclone derived from q-CRIP38 that produces an hADA-cDNA containing amphotropic retroviral vector LgAL(AMo + PyFlO l), was maintained in high glucose (4.5 g/L) a modified essential medium containing 10% heat-inactivated fetal calf serum (FCS), 100 pg/mL streptomycin, and 100 U/ mL penicillin.
All BM transplantations were performed in lethally irradiated BCBA recipients. For the CFU-S assay the mice were killed after 12 days and the spleens were evaluated for the presence of macroscopic colonies.39 Untransplanted lethally irradiated mice served as controls for endogenous CFU-S surviving the irradiation. In the presented experiments the number of background CFU-S was 0.5 k 0.1 (SEM) col/spleen (data from 60 animals). The number of CFU-S in a sample was calculated from dilutions of BM samples that gave rise to spleens containing (1): a significantly higher number of spleen colonies per spleen as compared with the radiation control (P < .05, Student's t-test) and (2) on average 10 or fewer spleen colonies per spleen. The number of spleen colonies detected in transplanted mice, was corrected for the number of endogenous CFU-S surviving the irradiation, in parallel experiments.
MRA-CFU-S present in a BM sample were assayed by assessing the number of CFU-S in the femurs of three mice transplanted 13 days earlier. In exp. 1 the BM of the three primary recipients was pooled and three dilutions were transplanted into eight lethally irradiated recipients per dilution for the CFU-S assay. For exps. 2 and 3 the BM of each primary recipient was transplanted separately into four secondary recipients per dilution, resulting in a total of 12 secondary recipients per dilution. In parallel experiments untransplanted lethally irradiated mice served as a control for the number of endogenous MRA-CFU-S surviving the irradiation. The number of CFU-S present in the femurs of radiation controls was 21 k 3.7 (SEM) col/femur (data from 34 animals). The number of grafted MRA-CFU-S was obtained by correcting the number of CFU-S per femur in transplanted mice for the number detected in radiation control mice in parallel experiments.
BM from 7-week-old BCBA mice was harvested by flushing the femora and tibiae with HEPES-buffered (IO mmol/ L, pH = 6.7) Hank's Balanced Salt Solution (HBSS). The POC-I cells were seeded 1 day before cocultivation such that they were approximately 70% confluent on the following day. One hour before the cocultivation the feeder cells were irradiated (20 Gy, 0.70 Gy/min, 137Cs gamma-rays). The cocultures were initiated by replacing half of the culture medium by fresh medium containing BM cells and polybrene in final concentrations of 1 X IO6 nucleated cells/mL and 0.4 pg/mL, respectively, and where indicated in the text the hematopoietic growth factors hIL-la (10 U/mL; Biogen, Gentve, Switzerland), mIL-3 (500 U/mL, Behringwerke, Marburg, Germany), and rSCF (100 ng/mL; Amgen, Thousand Oaks, CA). The thymus, spleen, and BM from long-term reconstituted mice were isolated and passed through a fine mesh in HBSS to obtain single cell suspensions. The cells were subsequently pelleted and flash frozen in liquid nitrogen.
DNA isolation, restriction enzyme analysis, and electrophoresis were performed via standard procedures. Size-fractionated DNA was transferred to Hybond-N+ nylon membranes and hybridized to one of three different 32P-labeled hADA-cDNA probes. All probes were fragments isolated from pAMGI?' Probe 5'H, an 880-bp SstII-BglII fragment, detects the region 5' of the BglII site in the hADA-cDNA. Probe 3'H is a 520-bp fragment BglII-SstII fragment and detects the region 3' of the BglII site in the hADA-cDNA. Probe ADA is a 1.4-kb SstII-SstlI fragment and encompasses the entire hADA-cDNA. To visualize the results, the filters were exposed to Kodak X-OMAT AR x-ray films (Eastman Kodak, Rochester, NY) using intensifying screens at -70°C. For quantification purposes the filters were exposed to photostimulable storage phosphor imaging plates (Molecular Dynamics, Sunnyvale, CA). The plates were scanned with a 400A PhosphorImager (Molecular Dynamics) and the radioactivity was quantified as described in Johnston et al?3 Quantifications were performed on Southem blots of DNA that was cut with SstI. This enzyme cuts once in each of the LTRs of the LgAL(AMo + PyF101) vector, which results in vector fragments that comigrate independently of the site of integration of the viruses. After hybridization with the entire hADA-cDNA probe, three cross-hybridizing murine ADA fragments are detected (see also Fig 3B) . The signal from these crosshybridizing fragments was used to correct the hADA signal for the total amount of DNA present in the lane. To this end the hADA provirus per cell, in spleen cell DNA from a negative control mouse. The correlation coefficient between the calculated number of hADA copies per diploid genome and the relative hADA signals of this titration was 0.995 over the range tested (ie, 0,0.083,0.167, and 0.33 hADA copies per diploid genome). The extent of DNA breakdown was evaluated by dividing the signal from the two low molecular weight murine ADA fragments by the signal from the high molecular weight murine ADA fragment. Samples with a ratio higher than IO were excluded from the calculations.
Analysis of ADA-isozyme activity was performed as described by Meera Khan et al." Table 1 . In the first experiment we cocultured either normal or 5-FU pretreated BM for 3 or 5 days on POC-1 cells in the presence of IL-la and IL-3. Using normal BM the yield of MRA-CFU-S decreased significantly between 3 and 5 days of cocultivation (P < .05). In contrast, no loss of MRA-CFU-S was detected with 5-FU pretreated BM between these two time points. The transduction of MRA-CFU-S also appeared to be highly dependent on the culture conditions. Highest efficiencies were obtained in the 3-day coculture of normal BM cells. A 2-day longer cocultivation resulted not only in a significantly reduced number MRA-CFU-S but those that were detected were for the most part not transduced. One explanation for this result could be that most of the MRA-CFU-S infected at day 3 of coculture died or differentiated on continued culture. The remaining MRA-CFU-S at day 5 would then primarily consist of MRA-CFU-S that did not respond to the growth factors present during the cocultivation and were hence refractory to retroviral infection.
RESULTS

Factors affecting the survival and infection
After coculture, a substantial fraction of the hematopoietic cells in a dish remains attached to the fibroblastoid producer cells. To test whether this fraction contained MRA-CFU-S, we added the adherent cells to grafts. The inclusion of the adherent cell layer significantly improved the recovery of MRA-CFU-S (P < .05) (Table 1, exp. 2). When nonadherent cells were mixed with mock cocultivated POC-1 cells just before their transplantation, they produced similar numbers of MRA-CFU-S as the nonadherent cell fraction alone (not shown). Thus, the effect was not caused by an enhanced proliferation of MRA-CFU-S in vivo in the presence of coinjected POC-1 cells. Therefore, for the following experiments we included the adherent cell layer in the transplant. In vitro gene transfer can still be evaluated because in vivo infection of regenerating hematopoietic progenitor cells by virus produced by the coinjected POC-1 cells does not occur noticeably."
The transduction of MRA-CFU-S in the nonadherent cell fraction of the cocultivation with IL-1 a and IL-3 appeared + The number of grafted MRA-CFU-S-derived spleen colonies was obtained by correcting the number detected in transplanted animals for the number of MRA-CFU-S detected in untransplanted control mice, as described in Materials and Methods. § Spleen colonies were dissected and DNA was isolated from one half a colony. The DNA was digested with 6g/ll, size fractionated, blotted, and hybridized to the 5'FL-probe. After autoradiography, the probe was removed and the filters were rehybridized with the 3'FL probe. Presented is the number of colonies containing hADA-DNA versus the total number of analyzed grafted colonies.
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more efficient than in the adherent cells. However, this difference was not very pronounced and because the majority of MRA-CFU-S adhere, the absolute number of infected MRA-CFU-S was much higher in the total cell population compared with the nonadherent cell fraction alone. In the presence of IL-3, the infection efficiency was similar to that detected when both IL-la and IL-3 were present. In the absence of IL-3, the infection efficiency was drastically reduced. The yield of MRA-CFU-S after cocultivation of BM with POC-I cells was highest when both IL-1 a and IL-3 had been added to the coculture. When no growth factor was added or when only IL-la or IL-3 were included, the yields were significantly lower (P < .05).
To examine the effect of SCF on the recovery and infection of MRA-CFU-S, we performed coculture experiments with normal or 5-FU pretreated BM (Table I, exp. 3) . The survival of MRA-CFU-S derived from normal BM was best in the presence of only SCF. The addition of IL-3 resulted in a lower yield of MRA-CFU-S (P < .05). When IL-la was also included the yield was even lower (P < .05), suggesting that IL-3 and IL-la in conjunction with SCF promote differentiation of MRA-CFU-S during coculture. MRA-CFU-S yields from cocultures with 5-FU pretreated BM did not show significant differences, although they followed a similar pattern. The transduction of MRA-CFU-S in this experiment was again highest with the combination of IL-1 a and IL-3. The infection efficiency was in general lower in the presence of SCF, with the exception of cocultures of 5-FU pretreated BM in the presence of IL-la and IL-3. Under these conditions the addition of SCF appeared to be neutral with respect to infectivity.
To study the clonal relationship of the infected colonies we isolated their DNA and restricted it with the restriction enzyme BglII. This enzyme cuts only once in the retroviral vector. Thus, the size of the retroviral fragments depends on the position of the closest BglII site in the flanking chromosomal DNA. Because retroviruses integrate apparently at random in the host chromosomal DNA, the size of these junction fragments is characteristic for the integration site. By hybridizing the Southern blot filters consecutively with probes specific for the 5'-junction fragment and the 3'-junction fragment we could determine the size of both junction fragments separately. Infected spleen colonies with identical 5'-and 3'-junction fragments were considered to be formed by clonally related CFU-s. As an example the analysis of the CFU-S in the BM of one primary recipient is depicted in Fig 1. Only three different proviral integration patterns were detected in the 1 1 provirus-containing spleen colonies. Therefore, these were the progeny of only three CFU-S-forming cells. It can be seen that the CFU-S-forming cells were markedly heterogeneous with respect to the rate with which they had repopulated the marrow of the primary recipient. Approximately half of the CFU-S were formed by only one CFU-S forming cell. This variable repopulation rate and the fact that a highly proliferative clone was transduced must be taken into account when interpreting the integration data.
The analysis of CFU-S in the BM of the other two mice transplanted with the BM from the same coculture showed
Clonal analysis of the progeny ofA4RA-CFU-S.
two provirus-containing colonies out of 15 in recipient I1 and 0 out of 10 in recipient 111. The proviral integration patterns of the two colonies, although identical to each other, did not resemble the patterns detected in Fig 1 (not shown) . Thus, because clonally related descendents of CFU-S-forming cells were only detected in the BM of the same primary recipient, we conclude that the transduced CFU-S-forming cells had proliferated in vivo and not in vitro in this experiment. If in vitro replication of transduced CFU-S-forming cells had occurred, descendents from the same clone should have been detected in more than one primary recipient. Therefore, the observed proliferation took place in the 13-day period during which the cells repopulated the marrow of the primary recipient.
The combined data are presented in Fig 2. It can be concluded that the clonal outgrowth phenomenon was reproducible as it was detected in experiments performed under identical conditions but at different time points; ie, the 3-day cocultivations in the presence of IL-la and IL3, when the nonadherent cells were transplanted (exps. 1 and 2) or when all cells were transplanted (exps. 2 and 3). The rate of clonal outgrowth of CFU-S-forming cells could not be attributed to specific coculture conditions; thus, it appears to be an intrinsic feature of hematopoietic repopulation by CFU-Sforming cells.
Expression of hADA in MRA-CFU-S-derived spleen colonies.
The frequency with which the hADA-cDNA was expressed in MRA-CFU-S-derived spleen colonies is summarized in Fig 2. As expected, no correlation was detected between expression and a particular growth factor combination. In MRA-CFU-S clones that gave rise to only one colony the frequency of expression was approximately 35%. The fact that 65% of the provirus containing spleen colonies did not express hADA could be because of chromosomal position effects. Of the 12 MRA-CFU-S that had produced more than one CFU-S, seven produced progeny in which hADA expression was identical in related colonies (Fig 2) . However, in five cases the expression was heterogeneous in the related colonies, despite their common integration site (Fig 2) . Thus, apart from chromosomal position effects a second, unidentified mechanism affects the expression of the retrovirally introduced hADA-cDNA.
Factors affecting the long-term persistence of transduced hematopoietic cells.
Although MRA-CFU-S copurify with PHSC in stem cell purification protocols3* they might not be the same cell. The MRA-CFU-S assay quantifies CFU-S regeneration in the marrow of lethally irradiated recipients. Because CFU-S are mainly restricted to the erythroid and myeloid lineage, the MRA-CFU-S assay provides no measure for the repopulation of the lymphoid lineage. To compare our results obtained in the MRA-CFU-S assay, with the infectivity of PHSC, additional groups of mice were transplanted with the cocultured BM, in parallel with the MRA-CFU-S exps. 2 and 3. Six months after transplantation, when PHSC have stably reconstituted the hematopoietic s y~t e m ,~ the mice were killed and their BM, spleen, and thymus were analyzed for the presence of retrovirally transduced cells.
Clonal analysis of the proviral integration patterns showed that repopulation had occurred by PHSC, because the prog- eny of one stem cell was detected in both the lymphoid lineage (thymus) and the myeloid lineage (BM). As an example the data are shown from the mice from exp. 3 that had received normal BM cocultured with IL-la and IL-3. The progeny of only one or a few transduced hematopoietic stem cells was detected in each primary recipient (Fig 3A, mice no. 1, 2,  and 6 ). The extent with which the three hematopoietic organs were repopulated with provirus-containing cells was approximately similar within one recipient, but vaned between recipients (Fig 3, B and C) . Expression of hADA was detected in circulating WBCs of two out of the six mice tested ( Fig   3D) . Thus, the LgAL(AMo + PyF101) vector enabled the sustained expression of hADA on long-term reconstitution of a hematopoietic system. However, expression in the circulating WBCs was not always correlated with the proviral copy number in the hematopoietic organs tested.
The quantification of the number of provirus copies per genome for the various coculture conditions analyzed in exps.
2 and 3 are summanzed in Fig 4. From these data it can be concluded that cocultivation in the presence of the growth factors lL-la and IL-3 reproducibly resulted in the highest number of retrovirally infected cells. Under these conditions, no large differences were observed between the use of normal or 5-FU pretreated BM as a source of PHSC. PHSC in the nonadherent cell fraction were infected with the same efficiency as PHSC harvested from both the adherent and the nonadherent cell fraction. Thus, infected and uninfected PHSC behaved similar with respect to adherence to the fibroblast cell layer (Fig 4, exp. 2). The addition of IL-la to IL-3 containing coculture medium significantly improved the persistence of infected cells compared with I L 3 alone (P < .05). The addition of only SCF to the cocultures did not result in an efficient infection of PHSC in normal BM. The addition of SCF to the cocultures with IL-la! and IL-3 had no drastic effect on the persistence of retrovirally infected cells in either normal or 5-FLJ pretreated BM. Therefore, we were not able 
DISCUSSION
Our approach to optimize procedures for the lasting genetic modification of the hematopoietic system was based on an interest not only to measure the extent of stem cell transduction, but also to assess the bone marrow regenerating capacity of the infected grafts and to determine the frequency with which the LgAL(AMo + PyFIOI) vector directed hADA expression.
In BMderived stromal cell layers, multipotent progenitors with self-renewal capacity are predominantly detected in the adherent NIH/3T3 cells, from which most murine retrovirus-producing cell lines are derived can, at least in part, substitute for marrow stromal la~ers.4~ Therefore, we tested whether cells with marrow repopulating ability adhered during cocultivation. We found that most of the MRA-CFU-S attached to the fibroblastoid POC-I cells during cocultivation. To optimize yields of BM regenerating cells we therefore currently include the adherent cell layer in the graft. A maximal recovery of primitive cells following cocultivation can be especially important in a (pre)-clinical setting, as in this case the number of donor cells for the procedure is limited.
After long-term reconstitution of the hematopoietic system of lethally irradiated mice, the highest number of transduced hematopoietic cells was detected on cocultivation in the presence ofboth IL-la and IL-3. A significantly lower number of transduced cells was detected when IL-la was omitted from such cocultures, indicating that ILla in combination with IL-3 promotes the long-term genetic modification of the hematopoietic system. The growth factor lL-la could act directly on PHSC during coculture or indirectly, by mediating growth factor production in BM accessory cells or in the virusproducing fibroblast monolayers. Indirect mechanisms, mediated through the induction of IL-6 during cocultivation, can be excluded because IL-la as well as IL-3 induce the production of large amounts of I L 6 during coculti~ation.'~ The addition of SCF to any of the cultures did not significantly improve the long-term persistence of transduced hematopoietic cells compared with the result obtained in the presence of IL-la and IL-3. However, SCF did considerably influence the yield of MRA-CFU-S after cocultivation. Highest yields were detected following cocultivation in the presence of SCF alone. Retrovirus packaging cells are subclones from the NIH/Swiss-mousederived embryonal fibroblast cell line NIH/3T3 and are thus very similar to Balb/c 3T3 embryonal fibroblasts, which are known to produce membrane bound SCF."* Therefore, it is likely that virusproducing POC-I cells also carry this molecule. Thus, either the addition of soluble SCF does not influence the long-term persistence of transduced hematopoietic cells whereas it does enhance the yield of MRA-CFU-S after coculture or sufficient (membranebound) SCF is produced by the POC-I cells to allow for the term genetic modification of the hematopoietic system, especially in normal BM, we suggest that the addition of ILla to cocultures can compensate for 5-FU pretreatment of BM donor mice. This observation has potential significance for clinical gene therapeutic applications. First, although 5-FU BM is enriched for primitive hematopoietic cells the total recovery of primitive cells from the BM is lower,'0 thus the number of transplanted PHSC is higher when normal BM cells can be used as a source ofcells. Second, given our results harsh pretreatment of patients with, for instance, 5-FU or cyclophosphamide to increase the transduction of autologous PHSC, does not seem necessary.
We have previously shown that the LgAUAMo + PyFIOI) vector directs gene expression in transplanted primary hematopoietic cells of the erythroid, myeloid, and lymphoid lineage~.~'*I* In the present study we have extended these results and quantified the expression frequency in the progeny of infected MRA-CFU-S. Approximately one out of three infected MRA-CFU-S-derived spleen colonies expressed Although the underlying mechanism is unknown, it is conceivable that vectors with other promoter/enhancer combinations or vectors carrying (parts of) locus control regions will not display this phenomenon. The frequency of expression (35%) is acceptable for the application of the vector in human gene therapy protocols for ADA-SCID patients. In these patients a selective repopulation advantage by ADApositive T cells is observed following allogeneic BM transplantati~n.'~ These characteristics, coupled with the observation that hADA expression persists in the circulating WBCs after long-term reconstitution of the hematopoietic system, render the vector suited for clinical gene therapy attempts.
hADA. However, clonally related spleen colonies were heterogeneous for hADA expression. Thus, apart from the site of integration of the provirus, which is known to be an imdifferent mechanism must modulate expression at a single position in the genome Of these Cells. It has been suggested that modulation of gene expression at a single site reflects changes in transcriptional activity as stem cellsdifferentiate.'' portant factor in the expression Of transduced sequences* a long-term reconstitution ofthe hematopoietic system ofW/WV mice.
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